Health

More in Health

Factlen ExplainerPsychiatric Medicine

FDA Approves Cobenfy for Schizophrenia and Bipolar I Disorder, Marking First New Mechanism in Decades

Clinical Psychiatrists 40%Neuropharmacologists 35%Patient Advocates 25%

5 sources · 29d ago

Factlen ExplainerPsychiatric Medicine

FDA Approves Cobenfy for Schizophrenia and Bipolar I Disorder, Marking First New Mechanism in Decades

Clinical Psychiatrists 40%Neuropharmacologists 35%Patient Advocates 25%

5 sources · 29d ago

Factlen Deep DiveVagus Nerve

Invasive Vagus Nerve Stimulation Shows Sustained Two-Year Remission in Severe Treatment-Resistant Depression

Clinical Researchers 40%Patients & Advocates 30%Healthcare Payers 30%

3 sources · 29d ago

Factlen Deep DiveVagus Nerve

Invasive Vagus Nerve Stimulation Shows Sustained Two-Year Remission in Severe Treatment-Resistant Depression

Clinical Researchers 40%Patients & Advocates 30%Healthcare Payers 30%

3 sources · 29d ago

Factlen ExplainerCardiovascular Health

FDA Approves Baxdrostat, a First-in-Class Aldosterone Inhibitor, for Hard-to-Treat Hypertension

Cardiovascular Researchers 40%Clinical Nephrologists 35%Public Health Advocates 25%

4 sources · 29d ago

Factlen ExplainerCardiovascular Health

FDA Approves Baxdrostat, a First-in-Class Aldosterone Inhibitor, for Hard-to-Treat Hypertension

Cardiovascular Researchers 40%Clinical Nephrologists 35%Public Health Advocates 25%

4 sources · 29d ago

Factlen ExplainerPancreatic Cancer

The Evidence Pack: How a RAS-Targeted Drug Nearly Doubled Survival in Advanced Pancreatic Cancer

Clinical Oncologists 40%Research Scientists 35%Industry Analysts 25%

5 sources · 29d ago

Factlen Deep DiveCellular Reprogramming

The Evidence Pack: How Partial Cellular Reprogramming is Entering Human Trials to Reverse Vision Loss

Longevity Researchers 40%Clinical Ophthalmologists 35%Safety & Bioethics Monitors 25%

5 sources · 29d ago

Factlen ExplainerRNA Therapeutics

The Evidence Pack: How a Novel RNA Drug Became the First to Reduce Pancreatitis Risk in Severe Hypertriglyceridemia

Clinical Lipidologists 40%RNA Therapeutics Researchers 35%Patient Advocacy Groups 25%

4 sources · 29d ago

Factlen ExplainerRNA Therapeutics

The Evidence Pack: How a Novel RNA Drug Became the First to Reduce Pancreatitis Risk in Severe Hypertriglyceridemia

Clinical Lipidologists 40%RNA Therapeutics Researchers 35%Patient Advocacy Groups 25%

4 sources · 29d ago

Factlen ExplainerRNA Therapeutics

The Evidence Pack: How a Novel RNA Drug Became the First to Reduce Pancreatitis Risk in Severe Hypertriglyceridemia

Clinical Lipidologists 40%RNA Therapeutics Researchers 35%Patient Advocacy Groups 25%

4 sources · 29d ago

Factlen ExplainerCeliac Pipeline

The Evidence Pack: How New Therapies Are Moving Celiac Disease Beyond the Gluten-Free Diet

Clinical Researchers 35%Patient Advocates 35%Factlen Editorial 30%

2 sources · 29d ago

Factlen ExplainerNutritional Psychiatry

The Evidence Pack: How Saffron Supplementation Matches SSRIs in Treating Mild-to-Moderate Depression

Integrative Psychiatrists 35%Clinical Researchers 35%Nutraceutical Regulators 30%

4 sources · 30d ago

Factlen ExplainerNutritional Psychiatry

The Evidence Pack: How Saffron Supplementation Matches SSRIs in Treating Mild-to-Moderate Depression

Integrative Psychiatrists 35%Clinical Researchers 35%Nutraceutical Regulators 30%

4 sources · 30d ago

Factlen ExplainerAddiction Medicine

The Evidence Pack: How GLP-1 Drugs Are Being Repurposed to Treat Alcohol Use Disorder

Addiction Researchers 40%Clinical Psychiatrists 35%Factlen Editorial Analysis 25%

4 sources · 30d ago

Factlen ExplainerAddiction Medicine

The Evidence Pack: How GLP-1 Drugs Are Being Repurposed to Treat Alcohol Use Disorder

Addiction Researchers 40%Clinical Psychiatrists 35%Factlen Editorial Analysis 25%

4 sources · 30d ago

Factlen ExplainerBarrier Repair

The Evidence Pack: How Ectoin and 'Preferential Exclusion' Are Rewriting Skin Barrier Repair

Cellular Biologists 35%Clinical Dermatologists 35%Cosmetic Chemists 30%

4 sources · 30d ago

Factlen ExplainerBarrier Repair

The Evidence Pack: How Ectoin and 'Preferential Exclusion' Are Rewriting Skin Barrier Repair

Cellular Biologists 35%Clinical Dermatologists 35%Cosmetic Chemists 30%

4 sources · 30d ago

Factlen ExplainerCognitive Science

The Evidence Pack: How L-Theanine Alters Brain Waves to Induce 'Calm Focus'

Neuroscience Researchers 41%Cognitive Performance Analysts 35%Clinical Skeptics 24%

8 sources · 30d ago

Factlen ExplainerCognitive Science

The Evidence Pack: How L-Theanine Alters Brain Waves to Induce 'Calm Focus'

Neuroscience Researchers 41%Cognitive Performance Analysts 35%Clinical Skeptics 24%

8 sources · 30d ago

Factlen ExplainerSkincare Science

The Evidence Pack: How Copper Peptides (GHK-Cu) Actually Work to Rebuild Skin Collagen

Clinical Researchers 40%Barrier-First Estheticians 35%Formulation Chemists 25%

3 sources · 30d ago

Factlen ExplainerSkincare Science

The Evidence Pack: How Copper Peptides (GHK-Cu) Actually Work to Rebuild Skin Collagen

Clinical Researchers 40%Barrier-First Estheticians 35%Formulation Chemists 25%

3 sources · 30d ago

Factlen ExplainerRespiratory Health

The Evidence Pack: How Nasal Breathing and Nitric Oxide Optimization Transform Sleep and Cardiovascular Health

Pulmonology & Cardiovascular Researchers 40%Sleep Medicine Specialists 40%Dental & Preventative Health Advocates 20%

4 sources · 30d ago

Factlen ExplainerRespiratory Health

The Evidence Pack: How Nasal Breathing and Nitric Oxide Optimization Transform Sleep and Cardiovascular Health

Pulmonology & Cardiovascular Researchers 40%Sleep Medicine Specialists 40%Dental & Preventative Health Advocates 20%

4 sources · 30d ago

Factlen ExplainerChronic Pain

The Evidence Pack: How Pain Reprocessing Therapy is Rewiring the Brain to Eliminate Chronic Pain

Neuroscience Researchers 40%Mind-Body Practitioners 35%Traditional Pain Specialists 25%

5 sources · 30d ago

Factlen ExplainerChronic Pain

The Evidence Pack: How Pain Reprocessing Therapy is Rewiring the Brain to Eliminate Chronic Pain

Neuroscience Researchers 40%Mind-Body Practitioners 35%Traditional Pain Specialists 25%

5 sources · 30d ago

Factlen Deep DiveCellular Aging

The Evidence Pack: How GlyNAC Supplementation Reverses Multiple Hallmarks of Biological Aging

Longevity Researchers 40%Clinical Skeptics 30%Geriatric Medicine Specialists 30%

5 sources · 30d ago

Factlen ResearchPhage Therapy

The Evidence Pack: How Synthetic Bacteriophages Are Defeating Antibiotic-Resistant Superbugs

Clinical Microbiologists 41%Synthetic Biologists 35%Regulatory Experts 24%

6 sources · 30d ago

Factlen ExplainerCognitive Health

The Science of Olfactory Enrichment: How Nightly Scents Can Dramatically Boost Memory

Neurobiology Researchers 45%Preventative Wellness Advocates 35%Clinical Skeptics 20%

3 sources · 30d ago

Factlen ExplainerCognitive Health

The Science of Olfactory Enrichment: How Nightly Scents Can Dramatically Boost Memory

Neurobiology Researchers 45%Preventative Wellness Advocates 35%Clinical Skeptics 20%

3 sources · 30d ago